Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Sonoma Pharmaceuticals (SNOA) Leases (2017 - 2025)

Sonoma Pharmaceuticals has reported Leases over the past 13 years, most recently at $642000.0 for Q4 2025.

  • For Q4 2025, Leases rose 439.5% year-over-year to $642000.0; the TTM value through Dec 2025 reached $642000.0, up 439.5%, while the annual FY2025 figure was $84000.0, 86.12% down from the prior year.
  • Leases for Q4 2025 was $642000.0 at Sonoma Pharmaceuticals, up from $479000.0 in the prior quarter.
  • Over five years, Leases peaked at $769000.0 in Q1 2021 and troughed at $84000.0 in Q1 2025.
  • A 5-year average of $464700.0 and a median of $504500.0 in 2022 define the central range for Leases.
  • On a YoY basis, Leases climbed as much as 439.5% in 2025 and fell as far as 86.12% in 2025.
  • Year by year, Leases stood at $623000.0 in 2021, then decreased by 24.4% to $471000.0 in 2022, then fell by 27.6% to $341000.0 in 2023, then crashed by 65.1% to $119000.0 in 2024, then soared by 439.5% to $642000.0 in 2025.
  • Business Quant data shows Leases for SNOA at $642000.0 in Q4 2025, $479000.0 in Q3 2025, and $536000.0 in Q2 2025.